FINSUM + Magnifi: The Trade War with China is Back

Magnifi in Action: Discover "Funds with Exposure to China"

Click on any fund in the chart below to dig deeper.

June 11, 2021

Tensions with China have been high, and are escalating during the Biden administration, which has continued the Trump era's tough stance on the country. A new piece of legislation reach the Senate this week that will target competition with China. The bill is limited in financial scope, but it targets $54 billion in subsidies related to semiconductors. This is aimed to reduce reliance on Taiwan, which looms as a larger geopolitical risk each year. The bill aims to boost manufacturing in the U.S. to level the playing field with research and innovation centers and other subsidies. Last week President Biden expanded the list of companies that were banned from U.S. investment due to ties with China’s Military.

(Washington)


 

FINSUM + Magnifi: This bill currently doesn’t have huge market implications outside the tech sector, but this legislation could continue to be tougher on Chinese trade.

Other news today: Gold Bullish but Eyes Still on Inflation and The Newest Tax Plan Could Cause an Imminent Correction
 


New call-to-action

Magnifi is changing the way we shop for investments, with the world’s first semantic search engine for finance that helps users discover, compare and buy investment products such as ETFs, mutual funds and stocks. As of June 2021, 380,000+ users with $534+ Billion in Assets Under Influence, have used Magnifi over 3,800,000 times. Try it for yourself today.

 

This blog is sponsored by Magnifi. The information and data are as of the publish date unless otherwise noted and subject to change. This material is provided for informational purposes only and should not be construed as individualized investment advice or an offer or solicitation to buy or sell securities tailored to your needs. This information covers investment and market activity, industry or sector trends, or other broad-based economic or market conditions and should not be construed as investment research or advice. Investors are urged to consult with their financial advisors before buying or selling any securities. Although certain information has been obtained from sources believed to be reliable, we do not guarantee its accuracy, completeness or fairness. Past performance is no guarantee of future results. This content may not be reproduced or distributed to any person in whole or in part without the prior written consent of Magnifi. [As a technology company, Magnifi provides access to tools and will be compensated for providing such access. Magnifi does not provide brokerage or custody services.]